TOXICON
Scope & Guideline
Fostering Knowledge in the Evolving Field of Toxicology
Introduction
Aims and Scopes
- Toxin Mechanisms and Pathophysiology:
Research exploring the biochemical and molecular mechanisms of action of various toxins, including snake venoms, bacterial toxins, and mycotoxins, contributes to understanding their pathophysiological effects on human and animal health. - Clinical Toxicology and Management:
Studies on clinical presentations, management strategies, and therapeutic interventions for toxin exposure, including snakebites and poisoning incidents, help improve patient outcomes and inform clinical practices. - Toxinology and Venom Research:
Focus on the characterization of venom components from various species, including snakes, spiders, and other venomous organisms, to elucidate their pharmacological properties and potential therapeutic applications. - Environmental and Food Toxicology:
Research that addresses the impact of environmental toxins, including mycotoxins, on human health and food safety, aiming to develop mitigation strategies and enhance public health. - Innovative Therapeutics and Antivenoms:
Exploration of novel therapeutic agents, including the development of antivenoms, small molecule inhibitors, and natural products that counteract the effects of toxins.
Trending and Emerging
- Molecular and Genetic Characterization:
There is an increasing trend towards the molecular and genetic characterization of toxins, including studies on the genomics of venomous species and the identification of specific toxin genes. - Mycotoxin Research and Food Safety:
Research on mycotoxins and their effects on food safety and public health is gaining prominence, particularly in relation to their prevalence in agricultural products and potential health impacts. - Neurotoxicology and Neurological Effects of Toxins:
Emerging studies are focusing on the neurotoxic effects of various venoms and toxins, exploring their impact on the nervous system and potential therapeutic applications. - Innovative Drug Development from Toxins:
There is a notable increase in research exploring the potential of toxins as leads for novel therapeutic agents, including anticancer drugs and antimicrobial peptides. - Environmental Impact of Toxins:
Research addressing the environmental consequences of toxins, including cyanotoxins and their effects on ecosystems, has become more prominent as ecological health becomes a priority.
Declining or Waning
- Traditional Antivenom Research:
There seems to be a waning interest in traditional antivenom research as newer methodologies, such as recombinant antivenoms and monoclonal antibodies, gain traction in the field. - General Toxicology Studies:
The journal appears to be shifting away from broad general toxicology studies that do not focus on specific toxins or mechanisms, favoring more targeted studies with clinical relevance. - Insect Venom Research:
Research specifically focused on insect venoms has decreased, possibly due to the increasing interest in more clinically relevant toxins from reptiles and mammals. - Historical Perspectives in Toxinology:
There has been a noticeable reduction in papers focusing on historical aspects of toxinology, as the field moves towards more contemporary and applied research.
Similar Journals
BIOLOGICAL & PHARMACEUTICAL BULLETIN
Connecting Research and Practice in PharmacologyBIOLOGICAL & PHARMACEUTICAL BULLETIN, published by the PHARMACEUTICAL SOC JAPAN, is a prominent peer-reviewed journal that serves the fields of medicine, pharmaceutical science, and pharmacology. With an ISSN of 0918-6158 and an E-ISSN of 1347-5215, this publication has been crucial in disseminating innovative research since its inception in 1993, and it continues to contribute significantly to the body of knowledge as it converges towards 2024. Despite being classified as a non-open access journal, it maintains a respectable Q3 ranking in Medicine (miscellaneous) and Q2 in Pharmaceutical Science, highlighting its critical role in advancing scientific discourse in these areas. With Scopus rankings placing it in the 51st percentile for Pharmaceutical Science and 38th percentile for Pharmacology, BIOLOGICAL & PHARMACEUTICAL BULLETIN is an essential resource for researchers, professionals, and students looking to stay abreast of cutting-edge developments and trends in biomedicine and drug development.
Toxins
Fostering collaboration in the fight against environmental toxins.Toxins, published by MDPI, is a leading open-access journal specializing in the field of toxicology, with a strong emphasis on the health implications of toxins across various environments. Established in 2009, this journal has quickly ascended to prominence, attaining a Q1 ranking in both the Health, Toxicology and Mutagenesis and Toxicology categories, underscoring its significant contribution to the scientific community. With an impressive Scopus ranking, placing it within the top percentile of related fields, Toxins serves as a vital resource for researchers, professionals, and students dedicated to advancing knowledge in toxicology and environmental health. The journal encourages the open dissemination of innovative research and critical reviews that explore the mechanisms, effects, and management of toxic substances, thus ensuring that vital research outcomes reach a global audience. For those looking to keep abreast of cutting-edge developments in the field, Toxins is an indispensable platform for scientific exchange and collaboration.
Journal of Toxicology
Empowering global research in toxicological science.Journal of Toxicology, published by HINDAWI LTD, stands as a pivotal open-access journal in the fields of toxicology and pharmacology since its inception in 2009. With an ISSN of 1687-8191 and an E-ISSN of 1687-8205, this journal is dedicated to disseminating high-quality research that critically examines the effects of toxic substances on living organisms. Located in Egypt and operating from their London office, it aims to provide an extensive platform for researchers worldwide to share findings that can inform better practices in safety and regulation. As of 2023, it has achieved significant recognition, holding a Q3 ranking in both the pharmacology and toxicology categories, and is indexed in Scopus with noteworthy percentile rankings (Toxicology: 57th and Pharmacology: 55th). With a focus on innovative studies and emerging areas such as environmental toxicology, biomarker research, and therapeutic interventions, the Journal of Toxicology invites both experienced researchers and students to contribute, thereby enhancing the breadth and depth of toxicological knowledge for the global scientific community.
CRITICAL REVIEWS IN TOXICOLOGY
Unveiling Innovations in Toxicological ResearchCRITICAL REVIEWS IN TOXICOLOGY, published by Taylor & Francis Ltd, stands as a preeminent journal within the field of toxicology, boasting an impressive Q1 ranking and holding the distinction of being ranked 12th out of 133 in the toxicology category according to Scopus, placing it in the top 91st percentile. With a continuous publication history since 1971 and a commitment to providing high-quality reviews, the journal offers critical insight into the latest research and advancements in toxicological sciences. While it is not an open-access journal, it provides numerous access options for both subscribers and institutions, ensuring that its extensive articles are widely available to the academic community. The journal's objectives are to disseminate comprehensive reviews that foster understanding and innovation in the assessment of chemical risks, environmental impacts, and the mechanisms of toxicity, making it an invaluable resource for researchers, professionals, and students dedicated to the science of toxicology.
COMPARATIVE BIOCHEMISTRY AND PHYSIOLOGY C-TOXICOLOGY & PHARMACOLOGY
Bridging Laboratory Discoveries with Real-World ApplicationsComparative Biochemistry and Physiology C-Toxicology & Pharmacology, published by Elsevier Science Inc, stands as a prominent resource in the fields of pharmacology, toxicology, and biochemical research. With its ISSN 1532-0456 and E-ISSN 1878-1659, this journal has carved out a significant niche, focusing on the comparative aspects of biochemical and physiological data across various species. Recognized for its impact in diverse fields, it boasts a Q1 ranking in Animal Science and Zoology, Aquatic Science, Health, Toxicology and Mutagenesis, alongside respectable standings in other related disciplines. Researchers and professionals can leverage this publication to access high-quality, peer-reviewed studies that advance the understanding of biochemical processes and their toxicological implications. The journal aims to bridge the gap between laboratory findings and real-world applications, fostering an environment for interdisciplinary collaboration. For academics seeking to enhance their knowledge or contribute to this impactful field, Comparative Biochemistry and Physiology C-Toxicology & Pharmacology serves as an invaluable platform.
Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis
Exploring the Nexus of Environment and HealthThe Journal of Environmental Science and Health Part C-Toxicology and Carcinogenesis is a vital publication in the fields of environmental science, toxicology, and cancer research, published by Taylor & Francis Inc. With an ISSN of 2689-6583 and E-ISSN 2689-6591, this journal provides a platform for peer-reviewed research that explores the intersection of environmental factors and health outcomes, particularly focusing on toxicological and carcinogenic impacts. Though it does not currently offer Open Access, it remains a significant contributor to academia with its current ranking in the Q4 category for Cancer Research and Q3 in Health, Toxicology and Mutagenesis. The journal has converged from 2020 to 2024 and aims to disseminate pioneering studies that inform public health policies and foster a deeper understanding of environmental toxins. Aspiring researchers, professionals, and students will find this journal to be an essential resource for the latest findings and discussions within these critical fields.
JOURNAL OF APPLIED TOXICOLOGY
Elevating Standards in Toxicological ResearchJOURNAL OF APPLIED TOXICOLOGY, published by Wiley, stands as a leading platform in the field of toxicology, focusing on the rigorous examination of chemical substances and their effects on biological systems. With an impressive Impact Factor, it ranks in the top quartile (Q2) for toxicology journals, reflecting its esteemed position within the scientific community. The journal, identifiable by its ISSN 0260-437X and E-ISSN 1099-1263, has been an invaluable resource since its inception in 1981, and it continues to serve as a conduit for innovative research and practical applications through 2024. Positioned at the forefront of the field, it garners recognition in the Scopus Rankings, where it ranks #31 out of 133 journals in the toxicology category, placing it in the 77th percentile—a testament to its contribution to the advancement of pharmacology and toxicological sciences. While not an open-access journal, it remains accessible to a wide audience of researchers, professionals, and students eager to explore cutting-edge findings in applied toxicology, making it a pivotal resource for enhancing knowledge and fostering collaboration in the field.
Toxicon-X
Exploring the Frontiers of Toxicological ResearchToxicon-X is a prestigious journal published by ELSEVIER, specializing in the dynamic field of toxicology. With an impact factor indicative of its excellence and rigor—ranked Q1 in Toxicology as of 2023, and positioned at #40 out of 133 in Scopus's Pharmacology, Toxicology, and Pharmaceutics category—this journal is a vital resource for researchers, practitioners, and students alike. Since its inception in 2019, Toxicon-X has embraced an Open Access model, enhancing accessibility and transparency of research findings. This ensures that crucial studies on toxic agents and their effects reach a broader audience, driving advancements in public health and safety. The journal is based in the United Kingdom and caters to a diverse international readership, with its scope encompassing novel research, reviews, and insights into emerging toxicological challenges. As we move towards the 2024 convergence year, Toxicon-X remains committed to fostering a deeper understanding of toxic substances, their mechanisms, and implications for human and environmental health.
Drug Research
Catalyzing Collaboration in Drug ResearchDrug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.
Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment
Advancing food safety through rigorous analysis and risk assessment.Food Additives and Contaminants Part A-Chemistry Analysis Control Exposure & Risk Assessment, published by Taylor & Francis Ltd, is a leading journal in the field of food science, toxicology, and public health. With an ISSN of 1944-0049 and an E-ISSN of 1944-0057, this esteemed publication has established itself as a vital resource for researchers and professionals involved in the analysis and regulation of food additives and contaminants. Since its inception and through its converged years from 2008 to 2012 and again from 2014 to 2023, the journal has maintained an impactful presence, notably achieving a Q2 ranking in diverse categories including Chemistry (miscellaneous) and Food Science, alongside commendable standings in Health and Environmental Health. The journal’s mission is to foster high-quality research by providing a platform for critical studies related to chemical analysis, exposure assessments, and risk management in food safety. By prioritizing engaging, peer-reviewed content, it aims to enhance understanding and mitigate risks associated with food additives, making it an indispensable tool for academics, practitioners, and policymakers alike.